When is genetic testing advised in colorectal (cancer of the colon or rectum) cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Genetic testing is advised in colorectal cancer for individuals with a known mutation in the family, those diagnosed with colorectal cancer before age 50, or those with specific tumor characteristics suggesting hereditary syndromes, as recommended by the NCCN guidelines 1.

Key Indications for Genetic Testing

  • A known mutation in the family
  • An individual with colorectal cancer and more than 10 adenomas
  • An individual affected with colorectal or endometrial cancer with one or more of the following:
    • Diagnosed before age 50
    • MSI-high or immunohistochemical staining showing the absence of one or more mismatch repair proteins
    • Synchronous or metachronous Lynch syndrome-related cancers
  • Classical familial adenomatous polyposis (FAP)
  • A first-degree relative with colorectal or endometrial cancer diagnosed before age 50
  • A first-degree relative with colorectal or endometrial cancer and another synchronous or metachronous LS-related cancer

Importance of Genetic Testing

Genetic testing is crucial in identifying hereditary syndromes, which impacts surveillance recommendations, surgical decisions, treatment options, and allows for cascade testing of family members who may benefit from enhanced screening and preventive measures 1. The most common hereditary syndromes tested for include Lynch syndrome and Familial Adenomatous Polyposis (FAP) 1.

Testing Approach

Testing typically involves tumor analysis first (microsatellite instability and immunohistochemistry), followed by germline genetic testing if abnormalities are found 1.

Benefits of Genetic Testing

The EGAPP Working Group concluded that there is moderate certainty that genetic testing for Lynch syndrome in patients with newly diagnosed colorectal cancer would provide moderate population benefit in reducing morbidity and mortality from Lynch syndrome in relatives 1.

From the Research

Genetic Testing for Colorectal Cancer

Genetic testing is advised in colorectal cancer when there is a family history of the disease or a personal history of colorectal cancer at a young age. The following are some scenarios where genetic testing is recommended:

  • A family history of colorectal cancer, particularly if there are multiple cases of colorectal cancer in the family or if the cancer occurred at a young age 2, 3
  • A personal history of colorectal cancer, especially if it occurred at a young age or if there are other signs of a hereditary cancer syndrome 3, 4
  • A known family history of a hereditary cancer syndrome, such as Lynch syndrome or familial adenomatous polyposis (FAP) 5, 6

Indications for Genetic Testing

Genetic testing is indicated in the following situations:

  • To confirm a diagnosis of a hereditary cancer syndrome, such as Lynch syndrome or FAP 5, 4
  • To identify individuals who are at increased risk of developing colorectal cancer due to a family history of the disease 2, 3
  • To guide cancer screening and prevention strategies, such as more frequent colonoscopies or prophylactic surgery 4

Types of Genetic Tests

There are several types of genetic tests that can be used to diagnose hereditary colorectal cancer syndromes, including:

  • Tests for mutations in the APC gene, which is associated with FAP 5, 6
  • Tests for mutations in the mismatch repair genes, which are associated with Lynch syndrome 5, 4
  • Tests for other genetic mutations that may increase the risk of colorectal cancer, such as the MYH gene 5

Related Questions

Can Lynne's condition be retested to determine if it is still active?
What are the recommendations for colon cancer screening in individuals at high risk for Colorectal Cancer (CRC)?
How is Lynch syndrome diagnosed?
What are the diagnostic tests for Lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer, HNPCC)?
Is genetic testing recommended for a 40-year-old male with a history of rectal cancer and basal cell carcinoma of the face, without a known family history?
What is the diagnosis for a 36-year-old female presenting with a recurrent, bright red, hot-to-the-touch rash on her arms, back, and chest, accompanied by recurring boils, poorly healing ulcers, and significant body pain, with laboratory findings indicating monoclonal plasma cells, an abnormal free light chain (FLC) ratio, and impaired lymphocyte and monocyte counts, as well as normal renal function with a calculated estimated Glomerular Filtration Rate (eGFR) greater than 60 milliliters per minute per 1.73 square meters?
What is the diagnosis for a 36-year-old female presenting with a recurrent, bright red, hot-to-the-touch rash on her arms, back, and chest, accompanied by recurring boils, poorly healing ulcers, and significant body pain, with laboratory findings indicating monoclonal plasma cells, an abnormal free light chain (FLC) ratio, and impaired lymphocyte and monocyte counts, as well as normal renal function with a calculated estimated Glomerular Filtration Rate (eGFR) greater than 60 milliliters per minute per 1.73 square meters?
What is the use of Ticagrelor (antiplatelet medication) in patients with Impaired renal function (dialysis)?
What are the differential diagnoses for a PET (Positron Emission Tomography) negative liver mass?
What is the difference between obstructive airflow disease, such as Chronic Obstructive Pulmonary Disease (COPD), and restrictive airflow disease?
What are the differential diagnoses for a patient with a negative PET (Positron Emission Tomography) scan and a liver mass with a possible bile duct (dyct) obstruction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.